These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11143198)

  • 1. Eradication of helminthic infections may be essential for successful vaccination against HIV and tuberculosis.
    Borkow G; Bentwich Z
    Bull World Health Organ; 2000; 78(11):1368-9. PubMed ID: 11143198
    [No Abstract]   [Full Text] [Related]  

  • 2. Helminthes could influence the outcome of vaccines against TB in the tropics.
    Elias D; Akuffo H; Britton S
    Parasite Immunol; 2006 Oct; 28(10):507-13. PubMed ID: 16965286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune modulation by helminthic infections: worms and viral infections.
    Kamal SM; El Sayed Khalifa K
    Parasite Immunol; 2006 Oct; 28(10):483-96. PubMed ID: 16965284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent infections that rise the HIV viral load.
    Bentwich Z
    J HIV Ther; 2003 Aug; 8(3):72-5. PubMed ID: 12951545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What information is needed to design effective vaccination against intracellular pathogens causing chronic disease?
    Bretscher PA; Hamilton D; Ogunremi O
    Expert Rev Vaccines; 2002 Aug; 1(2):179-92. PubMed ID: 12901557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helminths, human immunodeficiency virus and tuberculosis.
    Borkow G; Weisman Z; Leng Q; Stein M; Kalinkovich A; Wolday D; Bentwich Z
    Scand J Infect Dis; 2001; 33(8):568-71. PubMed ID: 11525348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.
    Borkow G; Bentwich Z
    Clin Diagn Lab Immunol; 2002 May; 9(3):505-7. PubMed ID: 11986252
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance.
    Elias D; Britton S; Kassu A; Akuffo H
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):475-84. PubMed ID: 17547511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenges of an HIV vaccine enterprise.
    Zinkernagel RM
    Science; 2004 Feb; 303(5662):1294-7; author reply 1294-7. PubMed ID: 14988536
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccines are essential in campaigns against HIV and TB, say researchers.
    Moszynski P
    BMJ; 2012 May; 344():e3625. PubMed ID: 22619222
    [No Abstract]   [Full Text] [Related]  

  • 11. The helminth HIV connection: time to act.
    Bentwich Z; Teicher CL; Borkow G
    AIDS; 2008 Aug; 22(13):1611-4. PubMed ID: 18670220
    [No Abstract]   [Full Text] [Related]  

  • 12. Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination?
    Rook GA; Hernández-Pando R; Zumla A
    J Infect Dis; 2009 Mar; 199(5):613-8. PubMed ID: 19199549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helminthiasis: new medical significance.
    Markus MB
    Trends Parasitol; 2002 May; 18(5):205. PubMed ID: 11983600
    [No Abstract]   [Full Text] [Related]  

  • 14. An act to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes. United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003. Public Law 108-25.
    United States. Congress
    US Statut Large; 2003 May; 117():711-50. PubMed ID: 16700110
    [No Abstract]   [Full Text] [Related]  

  • 15. Can worms defend our hearts? Chronic helminthic infections may attenuate the development of cardiovascular diseases.
    Magen E; Borkow G; Bentwich Z; Mishal J; Scharf S
    Med Hypotheses; 2005; 64(5):904-9. PubMed ID: 15780483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for a vaccine against HIV/AIDS.
    Katongole-Mbidde E
    J Int Assoc Physicians AIDS Care; 1997 Nov; 3(11):26-9. PubMed ID: 11364810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
    Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic immunization strategies for the control of HIV-1.
    Dorrell L
    Expert Rev Vaccines; 2005 Aug; 4(4):513-20. PubMed ID: 16117708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cynomolgus macaques immunized with two HIV-1 Tat stabilized proteins raise strong and long-lasting immune responses with a pattern of Th1/Th2 response differing from that in mice.
    Turbant S; Martinon F; Moine G; Le Grand R; Léonetti M
    Vaccine; 2009 Aug; 27(39):5349-56. PubMed ID: 19607953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The HIV vaccine].
    Smith KA
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):723-8. PubMed ID: 15562781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.